Close

DYNC1I2

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

DYNC1I2 belongs to the dynein intermediate chain family. The encoded protein is a non-catalytic component of the cytoplasmic dynein 1 complex, which acts as a retrograde microtubule motor to transport organelles and vesicles. A pseudogene of this gene is located on chromosome 10.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-YC0087 Anti-DYNC1I2 (CBYCJ-014) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human CBYCJ-014 Rabbit scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0088 Anti-DYNC1I2 (74.1) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Bovine 74.1 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0089 Anti-DYNC1I2 (CBYCJ-015) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human CBYCJ-015 Rabbit scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0710 Anti-DYNC1I2 (CBYCD-459) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 Human CBYCD-459 Rabbit scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0987 Anti-DYNC1I2 (CBYCJ-014) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human CBYCJ-014 Rabbit scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0988 Anti-DYNC1I2 (74.1) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Bovine 74.1 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC0989 Anti-DYNC1I2 (CBYCJ-015) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human CBYCJ-015 Rabbit scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YC1610 Anti-DYNC1I2 (CBYCD-459) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 Human CBYCD-459 Rabbit scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.